Evaluation of Efficacy of S-1 in the Treatment of Advanced Pancreatic Cancer
JIN Feng
Abstract：Objective:To evaluate the effect and safety of S-1 in the treatment of advanced pancreatic cancer.Method:A total of 60 patients were randomly divided into the control group and the treatment group,30 patients treated with S-1 and gemcitabine in the treatment group,and 30 patients treated with gemcitabine in the control group.Result:The curative effect of the treatment group compared to the control group,there was significant difference(P<0.01).There was no statistically significant difference between two groups in CEA and CA199(P>0.05).KPS of the treatment group was higher than that of treatment before,the effect was superior to the control group(P<0.05).And adverse reaction rate of the treatment group was no statistically significant difference compared with the control group(P>0.05).Conclusion:S-1 combinded chemotherapy has a better effect and safety on the patients with advanced pancreatic cancer.
Keywords：S-1Advanced pancreatic cancerClinical study
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 3-5 )